APA (7th ed.) Citation

Chen, X., Zhang, X., Xiang, X., Fang, X., & Feng, S. (2024). Effects of glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in high-risk type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabetology & Metabolic Syndrome, 16(1), 1. https://doi.org/10.1186/s13098-024-01497-4

Chicago Style (17th ed.) Citation

Chen, Xiaomei, Xuge Zhang, Xiang Xiang, Xiang Fang, and Shenghong Feng. "Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiovascular Outcomes in High-risk Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials." Diabetology & Metabolic Syndrome 16, no. 1 (2024): 1. https://doi.org/10.1186/s13098-024-01497-4.

MLA (9th ed.) Citation

Chen, Xiaomei, et al. "Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiovascular Outcomes in High-risk Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials." Diabetology & Metabolic Syndrome, vol. 16, no. 1, 2024, p. 1, https://doi.org/10.1186/s13098-024-01497-4.